Cytogenetics in the genomic era
- 1 September 2020
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 33 (3) , 101196
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- V. Molecular classification and risk stratification of myelomaHematological Oncology, 2013
- Cytogenetic risk stratification in chronic myelomonocytic leukemiaHaematologica, 2010
- Prognostic Significance of Copy-Number Alterations in Multiple MyelomaJournal of Clinical Oncology, 2009
- Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex KaryotypeJournal of Clinical Oncology, 2008
- Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AMLBlood, 2008
- Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgVH status and immunophenotypingLeukemia, 2007
- Guidance for Fluorescence in Situ Hybridization Testing in Hematologic DisordersThe Journal of Molecular Diagnostics, 2007
- Der(6)t(1;6)(q21–23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasiaBritish Journal of Haematology, 2005
- Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotypeLeukemia, 2002
- Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)Blood, 2002